Skip to content
Tenfell
Awarded contract
Published 03 Apr 2024

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

NHS England · London

Key facts

Awarded
11 Mar 2024
Contract starts
31 Mar 2024
Contract ends
31 Mar 2028
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 6 suppliers

SupplierValue
Baxter Healthcare Ltd—
ITH Pharma Limited—
SCIENSUS PHARMA SERVICES LTD—
Qualasept Ltd t/a Bath ASU—
Quantum Pharmaceutical—
LloydsPharmacy Clinical Homecare—

Description

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01

Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.